| PHILADELPHIA HEALTH & EDUCATION CORPORATION Patent applications |
| Patent application number | Title | Published |
|---|
| 20100184843 | IDENTIFICATION OF A PIN SPECIFIC GENE AND PROTEIN (PIN-1) USEFUL AS A DIAGNOSTIC TREATMENT FOR PROSTATE CANCER - The invention relates to nucleic acids encoding a mammalian ABCA5 gene, and proteins encoded thereby, whose expression is increased in certain diseases, disorders, or conditions, including, but not limited to, PIN. Further, the invention relates to diagnostic assays for identifying the DNA-binding protein ABCA5 (also known as PIN-1). The invention also relates to oligonucleotide sequence(s) or antibodies that specifically bind with ABCA5 or variants thereof. | 07-22-2010 |
| 20100178250 | Method of Local Delivery of Bioactive and Diagnostic Agents Using Magnetizable Bone Cement - A method of making a magnetizable implant, the method includes mixing a curable matrix and the at least one of the bioactive agent or the diagnostic agent associated with the magnetizable carrier to form a magnetizable curable matrix; implanting the magnetizable curable matrix in a cavity in a body of a mammal whereby the magnetizable curable matrix takes on a shape of the cavity and forms a molded magnetizable curable matrix; simultaneously curing the molded magnetizable curable matrix and applying the magnetic field and thereby causing the at least one of the bioactive agent or the diagnostic agent associated with a magnetizable carrier to move and arrange within the molded magnetizable curable matrix at or near an interface between the cavity and an outer surface of the molded magnetizable curable bioactive matrix. | 07-15-2010 |
| 20090081712 | ATM-Dependent Phosphorylation of Sp1 Is Involved in the Cellular Response to DNA Damage and Enhances Cellular Survival After DNA Damage - The present invention is related to the discovery that phosphorylation of SP1 (SEQ ID NO.: 2) at serine residue 101 (known herein as phosphoserine | 03-26-2009 |
